Predicting differential responses to structured treatment interruptions during HAART
From MaRDI portal
Publication:253613
DOI10.1016/j.bulm.2003.11.003zbMath1334.92224OpenAlexW2128636484WikidataQ51635697 ScholiaQ51635697MaRDI QIDQ253613
Denise E. Kirschner, Seema H. Bajaria, Glenn F. Webb
Publication date: 8 March 2016
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/2027.42/83362
Related Items (20)
Free terminal time optimal control problem of an HIV model based on a conjugate gradient method ⋮ Modeling HIV persistence, the latent reservoir, and viral blips ⋮ Optimal treatment strategies derived from a HIV model with drug-resistant mutants ⋮ Costs versus benefits: best possible and best practical treatment regimens for HIV ⋮ Within-host virus models with periodic antiviral therapy ⋮ A MATHEMATICAL MODEL FOR THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA ⋮ The work of Glenn F. Webb ⋮ Analysis and simulation of a delayed HIV model with reaction-diffusion and sliding control ⋮ Multiobjective optimal control of HIV dynamics ⋮ Emergence of HIV-1 drug resistance during antiretroviral treatment ⋮ Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting ⋮ Mathematical Modeling of HIV-1 Infection and Drug Therapy ⋮ An age-structured model with immune response of HIV infection: modeling and optimal control approach ⋮ Mutation and control of the human immunodeficiency virus ⋮ An analysis of functional curability on HIV infection models with Michaelis-Menten-type immune response and its generalization ⋮ Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia ⋮ Optimal control of an age-structured model of HIV infection ⋮ The Effects of HIV-1 Infection on Latent Tuberculosis ⋮ An Intracellular Delay-Differential Equation Model of the HIV Infection and Immune Control ⋮ Dynamics of HIV infection in lymphoid tissue network
This page was built for publication: Predicting differential responses to structured treatment interruptions during HAART
